{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T13:03:57Z","timestamp":1774098237806,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-10684-w","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T23:12:58Z","timestamp":1752707578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical outcomes of a 12-week, first treatment with methylphenidate in an Italian representative sample of children and adolescents with ADHD"],"prefix":"10.1038","volume":"15","author":[{"given":"Alessandro","family":"Crippa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Rosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Mauri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Valli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Nobile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Salandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Trabattoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Molteni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"10684_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. (American Psychiatric Association, 2022).","DOI":"10.1176\/appi.books.9780890425787"},{"key":"10684_CR2","doi-asserted-by":"publisher","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 396, 1204\u201322. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9 (2020).","DOI":"10.1016\/S0140-6736(20)30925-9"},{"key":"10684_CR3","doi-asserted-by":"publisher","first-page":"4823","DOI":"10.1038\/s41380-023-02228-3","volume":"28","author":"S Cortese","year":"2023","unstructured":"Cortese, S. et al. Incidence, prevalence, and global burden of ADHD from 1990 to 2019 across 204 countries: Data, with critical re-analysis, from the Global Burden of Disease study. Mol. Psychiatry 28, 4823\u20134830. https:\/\/doi.org\/10.1038\/s41380-023-02228-3 (2023).","journal-title":"Mol. Psychiatry"},{"issue":"12","key":"10684_CR4","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s00787-017-1005-z","volume":"26","author":"L Reale","year":"2017","unstructured":"Reale, L. et al. Comorbidity prevalence and treatment outcome in children and adolescents with ADHD. Eur Child Adolesc Psychiatry 26(12), 1443\u20131457. https:\/\/doi.org\/10.1007\/s00787-017-1005-z (2017).","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"17","key":"10684_CR5","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.12998\/wjcc.v7.i17.2420","volume":"7","author":"S Gnanavel","year":"2019","unstructured":"Gnanavel, S., Sharma, P., Kaushal, P. & Hussain, S. Attention deficit hyperactivity disorder and comorbidity: A review of literature. World J. Clin. Cases 7(17), 2420\u20132426. https:\/\/doi.org\/10.12998\/wjcc.v7.i17.2420 (2019).","journal-title":"World J. Clin. Cases"},{"key":"10684_CR6","unstructured":"National Institute for Health and Care Excellence. Attention Deficit Hyperactivity Disorder: Diagnosis and Management. https:\/\/www.nice.org.uk\/guidance\/NG87. (2018)."},{"key":"10684_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-024-00495-0","volume":"10","author":"SV Faraone","year":"2024","unstructured":"Faraone, S. V. et al. Attention-deficit\/hyperactivity disorder. Nat. Rev. Dis. Primers 10, 11. https:\/\/doi.org\/10.1038\/s41572-024-00495-0 (2024).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10684_CR8","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41380-018-0116-3","volume":"24","author":"A Caye","year":"2019","unstructured":"Caye, A., Swanson, J. M., Coghill, D. & Rohde, L. A. Treatment strategies for ADHD: An evidence-based guide to select optimal treatment. Mol. Psychiatry 24(3), 390\u2013408. https:\/\/doi.org\/10.1038\/s41380-018-0116-3 (2019).","journal-title":"Mol. Psychiatry"},{"issue":"9","key":"10684_CR9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S2215-0366(18)30269-4","volume":"5","author":"S Cortese","year":"2018","unstructured":"Cortese, S. et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: A systematic review and network meta-analysis. Lancet Psychiatry 5(9), 727\u2013738. https:\/\/doi.org\/10.1016\/S2215-0366(18)30269-4 (2018).","journal-title":"Lancet Psychiatry"},{"key":"10684_CR10","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s40120-022-00392-2","volume":"11","author":"J Quintero","year":"2022","unstructured":"Quintero, J., Guti\u00e9rrez-Casares, J. R. & \u00c1lamo, C. Molecular characterisation of the mechanism of action of stimulant drugs lisdexamfetamine and methylphenidate on ADHD neurobiology: A review. Neurol. Ther. 11, 1489\u20131517. https:\/\/doi.org\/10.1007\/s40120-022-00392-2 (2022).","journal-title":"Neurol. Ther."},{"issue":"1","key":"10684_CR11","first-page":"44","volume":"41","author":"E Serrano-Troncoso","year":"2013","unstructured":"Serrano-Troncoso, E., Guidi, M. & Alda-D\u00edez, J. \u00c1. Is psychological treatment efficacious for attention deficit hyperactivity disorder (ADHD)? Review of non-pharmacological treatments in children and adolescents with ADHD. Actas Esp Psiquiatr. 41(1), 44\u201351 (2013).","journal-title":"Actas Esp Psiquiatr."},{"issue":"6","key":"10684_CR12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/sj.mp.4001507","volume":"9","author":"ND Volkow","year":"2004","unstructured":"Volkow, N. D., Fowler, J. S., Wang, G. J. & Swanson, J. M. Dopamine in drug abuse and addiction: Results from imaging studies and treatment implications. Mol. Psychiatry 9(6), 557\u2013569. https:\/\/doi.org\/10.1038\/sj.mp.4001507 (2004).","journal-title":"Mol. Psychiatry"},{"issue":"8","key":"10684_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.biopsych.2013.10.005","volume":"76","author":"DR Coghill","year":"2014","unstructured":"Coghill, D. R. et al. Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit\/hyperactivity disorder: Evidence from a systematic review and a meta-analysis. Biol. Psychiatry 76(8), 603\u2013615. https:\/\/doi.org\/10.1016\/j.biopsych.2013.10.005 (2014).","journal-title":"Biol. Psychiatry"},{"key":"10684_CR14","unstructured":"SINPIA\u2014Italian Society of Neuropsychiatry of Childhood and Adolescence. Linee-guida per la diagnosi e la terapia farmacologica del Disturbo da Deficit Attentivo con Iperattivit\u00e0 (ADHD) in et\u00e0 evolutiva. http:\/\/www.iss.it\/binary\/wpop\/cont\/SINPIA_L.g.ADHD.1116940207.pdf (2002)."},{"issue":"9","key":"10684_CR15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2215-0366(17)30127-X","volume":"4","author":"G Signorini","year":"2017","unstructured":"Signorini, G. et al. Architecture and functioning of child and adolescent mental health services: A 28-country survey in Europe. Lancet Psychiatry 4(9), 715\u2013724. https:\/\/doi.org\/10.1016\/S2215-0366(17)30127-X (2017).","journal-title":"Lancet Psychiatry"},{"issue":"12","key":"10684_CR16","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1080\/14740338.2017.1389894","volume":"16","author":"A Clavenna","year":"2017","unstructured":"Clavenna, A. & Bonati, M. Pediatric pharmacoepidemiology\u2014safety and effectiveness of medicines for ADHD. Expert Opin Drug Saf. 16(12), 1335\u20131345. https:\/\/doi.org\/10.1080\/14740338.2017.1389894 (2017).","journal-title":"Expert Opin Drug Saf."},{"key":"10684_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-019-4524-0","volume":"19","author":"M Bonati","year":"2019","unstructured":"Bonati, M., Cartabia, M. & Zanetti, M. Waiting times for diagnosis of attention-deficit hyperactivity disorder in children and adolescents referred to Italian ADHD centers must be reduced. BMC Health Serv. Res. 19, 1\u201310. https:\/\/doi.org\/10.1186\/s12913-019-4524-0 (2019).","journal-title":"BMC Health Serv. Res."},{"key":"10684_CR18","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1177\/1087054715599573","volume":"22","author":"M Bonati","year":"2018","unstructured":"Bonati, M. et al. A Regional ADHD center-based network project for the diagnosis and treatment of children and adolescents with ADHD. J. Atten. Disord. 22, 1173\u20131184. https:\/\/doi.org\/10.1177\/1087054715599573 (2018).","journal-title":"J. Atten. Disord."},{"key":"10684_CR19","doi-asserted-by":"publisher","unstructured":"Bonati, M., Scarpellini, F., Cartabia, M., Zanetti, M., & Lombardy ADHD Group. Ten years (2011\u20132021) of the Italian Lombardy ADHD register for the diagnosis and treatment of children and adolescents with ADHD. Children. 8(7), 598. https:\/\/doi.org\/10.3390\/children8070598 (2021).","DOI":"10.3390\/children8070598"},{"issue":"12","key":"10684_CR20","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1001\/archpsyc.56.12.1073","volume":"56","author":"MTA Cooperative Group","year":"1999","unstructured":"MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit\/hyperactivity disorder. Arch. Gen. Psychiatry 56(12), 1073\u20131086. https:\/\/doi.org\/10.1001\/archpsyc.56.12.1073 (1999).","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10684_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s13318-016-0346-1","volume":"42","author":"MD Cherm\u00e1","year":"2017","unstructured":"Cherm\u00e1, M. D. et al. Methylphenidate for treating ADHD: A naturalistic clinical study of methylphenidate blood concentrations in children and adults with optimized dosage. Eur. J. Drug Metab. Pharmacokinet. 42(2), 295\u2013307. https:\/\/doi.org\/10.1007\/s13318-016-0346-1 (2017).","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"10","key":"10684_CR22","doi-asserted-by":"publisher","first-page":"e0253727","DOI":"10.1371\/journal.pone.0253727","volume":"16","author":"K Kaalund-Brok","year":"2021","unstructured":"Kaalund-Brok, K. et al. Outcomes of a 12-week ecologically valid observational study of first treatment with methylphenidate in a representative clinical sample of drug na\u00efve children with ADHD. PLoS ONE 16(10), e0253727. https:\/\/doi.org\/10.1371\/journal.pone.0253727 (2021).","journal-title":"PLoS ONE"},{"issue":"10","key":"10684_CR23","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.3390\/jcm11102922","volume":"11","author":"P Ventura","year":"2022","unstructured":"Ventura, P. et al. Methylphenidate use for emotional dysregulation in children and adolescents with ADHD and ADHD and ASD: A naturalistic study. J. Clin. Med. 11(10), 2922. https:\/\/doi.org\/10.3390\/jcm11102922 (2022).","journal-title":"J. Clin. Med."},{"issue":"1","key":"10684_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s40268-023-00445-3","volume":"24","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Efficacy and safety of methylphenidate and atomoxetine in medication-naive children with attention-deficit hyperactivity disorder in a real-world setting. Drugs R&D 24(1), 29\u201339. https:\/\/doi.org\/10.1007\/s40268-023-00445-3 (2024).","journal-title":"Drugs R&D"},{"issue":"2","key":"10684_CR25","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00787-023-02158-z","volume":"33","author":"TB Houmann","year":"2024","unstructured":"Houmann, T. B. et al. Early treatment response as predictor of long-term outcome in a clinical cohort of children with ADHD. Eur. Child. Adolesc. Psychiatry 33(2), 357\u2013367. https:\/\/doi.org\/10.1007\/s00787-023-02158-z (2024).","journal-title":"Eur. Child. Adolesc. Psychiatry"},{"issue":"4","key":"10684_CR26","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1177\/13623613211065545","volume":"26","author":"R Rosello","year":"2022","unstructured":"Rosello, R. et al. Cognitive, social, and behavioral manifestations of the co-occurrence of autism spectrum disorder and attention-deficit\/hyperactivity disorder: A systematic review. Autism 26(4), 743\u2013760. https:\/\/doi.org\/10.1177\/13623613211065545 (2022).","journal-title":"Autism"},{"issue":"8","key":"10684_CR27","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s00406-022-01386-9","volume":"272","author":"P De Rossi","year":"2022","unstructured":"De Rossi, P. et al. Clinical characteristics of children and adolescents with ADHD with or without methylphenidate prescription at their first diagnostic assessment. Eur. Arch. Psychiatry Clin. Neurosci. 272(8), 1437\u20131442. https:\/\/doi.org\/10.1007\/s00406-022-01386-9 (2022).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"11","key":"10684_CR28","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1007\/s10826-018-1207-0","volume":"27","author":"L Vanzin","year":"2018","unstructured":"Vanzin, L. et al. The effectiveness of coping power program for ADHD: An observational outcome study. J. Child Fam. Stud. 27(11), 3554\u20133563. https:\/\/doi.org\/10.1007\/s10826-018-1207-0 (2018).","journal-title":"J. Child Fam. Stud."},{"issue":"1","key":"10684_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1017\/bec.2020.3","volume":"37","author":"L Vanzin","year":"2020","unstructured":"Vanzin, L. et al. Does ACT-group training improve cognitive domain in children with attention deficit hyperactivity disorder? A single-arm, open-label study. Behav. Chang. 37(1), 33\u201344. https:\/\/doi.org\/10.1017\/bec.2020.3 (2020).","journal-title":"Behav. Chang."},{"issue":"5","key":"10684_CR30","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1707\/1664.18220","volume":"30","author":"L Reale","year":"2014","unstructured":"Reale, L., Zanetti, M., Cartabia, M., Fortinguerra, F. & Bonati, M. Due anni di attivit\u00e0 del Registro ADHD della Regione Lombardia: Analisi dei percorsi di cura diagnostici e terapeutici. Ric&Pra 30(5), 198\u2013211. https:\/\/doi.org\/10.1707\/1664.18220 (2014).","journal-title":"Ric&Pra"},{"key":"10684_CR31","unstructured":"Germinario, E.A.P., Arcieri, R., Marzi, M., Panei, P., Vella, S. Registro nazionale ADHD (Attention-Deficit\/Hyperactivity Disorder): Dati dal 2007 al 2016. Rapporti ISTISAN 16\/37. https:\/\/www.iss.it\/documents\/20126\/45616\/16_37_web.pdf\/c8e4e341-238f-ad08-545b-928b0255aded?t=1581095636154 (Istituto Superiore di Sanit\u00e0, 2016)."},{"issue":"5","key":"10684_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S2215-0366(23)00042-1","volume":"10","author":"KKC Man","year":"2023","unstructured":"Man, K. K. C. Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the attention deficit hyperactivity disorder drugs use chronic effects (ADDUCE) study. Lancet Psychiatry 10(5), 323\u2013333. https:\/\/doi.org\/10.1016\/S2215-0366(23)00042-1 (2023).","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"10684_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11920-019-1020-5","volume":"21","author":"KM Antshel","year":"2019","unstructured":"Antshel, K. M. & Russo, N. Autism spectrum disorders and ADHD: Overlapping phenomenology, diagnostic issues, and treatment considerations. Curr. Psychiatry Rep. 21(5), 34. https:\/\/doi.org\/10.1007\/s11920-019-1020-5 (2019).","journal-title":"Curr. Psychiatry Rep."},{"issue":"3","key":"10684_CR34","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1037\/0894-4105.18.3.543","volume":"18","author":"TW Fraizer","year":"2004","unstructured":"Fraizer, T. W., Demaree, H. A. & Youngstrom, E. A. Meta-analysis of intellectual and neuropsychological test performance in attention deficit\/hyperactivity disorder. Neuropsychology 18(3), 543\u2013555. https:\/\/doi.org\/10.1037\/0894-4105.18.3.543 (2004).","journal-title":"Neuropsychology"},{"issue":"1","key":"10684_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1089\/cap.2018.0095","volume":"29","author":"D Efron","year":"2019","unstructured":"Efron, D. et al. Prevalence and predictors of medication use in children with attention-deficit\/hyperactivity disorder: Evidence from a community-based longitudinal study. J. Child Adolesc. Psychopharmacol. 29(1), 50\u201357. https:\/\/doi.org\/10.1089\/cap.2018.0095 (2019).","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10684_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/cap.2016.0017","volume":"27","author":"MG Sawyer","year":"2017","unstructured":"Sawyer, M. G. et al. The prevalence of stimulant and antidepressant use by Australian children and adolescents with attention-deficit\/hyperactivity disorder and major depressive disorder: A national survey. J. Child Adolesc. Psychopharmacol. 27, 177\u2013184. https:\/\/doi.org\/10.1089\/cap.2016.0017 (2017).","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"13","key":"10684_CR37","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1177\/070674370605101306","volume":"51","author":"MD Brownell","year":"2006","unstructured":"Brownell, M. D., Mayer, T. & Chateau, D. The incidence of methylphenidate use by Canadian children: What is the impact of socioeconomic status and urban or rural residence?. Can. J. Psychiatry 51(13), 847\u2013854. https:\/\/doi.org\/10.1177\/070674370605101306 (2006).","journal-title":"Can. J. Psychiatry"},{"key":"10684_CR38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jpsychires.2015.01.011","volume":"62","author":"CH Cheung","year":"2015","unstructured":"Cheung, C. H. et al. Childhood predictors of adolescent and young adult outcome in ADHD. J. Psychiatr. Res. 62, 92\u2013100. https:\/\/doi.org\/10.1016\/j.jpsychires.2015.01.011 (2015).","journal-title":"J. Psychiatr. Res."},{"key":"10684_CR39","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00787-018-1211-3","volume":"28","author":"FD Mowlem","year":"2019","unstructured":"Mowlem, F. D. et al. Sex differences in predicting ADHD clinical diagnosis and pharmacological treatment. Eur. Child Adolesc. Psychiatry 28, 481\u2013489. https:\/\/doi.org\/10.1007\/s00787-018-1211-3 (2019).","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10684_CR40","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00787-016-0820-y","volume":"25","author":"M van Lieshout","year":"2016","unstructured":"van Lieshout, M. et al. A 6-year follow-up of a large European cohort of children with attention-deficit\/hyperactivity disorder-combined subtype: Outcomes in late adolescence and young adulthood. Eur. Child Adolesc Psychiatry 25, 1007\u20131017. https:\/\/doi.org\/10.1007\/s00787-016-0820-y (2016).","journal-title":"Eur. Child Adolesc Psychiatry"},{"issue":"1","key":"10684_CR41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00787-023-02145-4","volume":"33","author":"S Grazioli","year":"2024","unstructured":"Grazioli, S. Exploring telediagnostic procedures in child neuropsychiatry: Addressing ADHD diagnosis and autism symptoms through supervised machine learning. Eur. Child. Adolesc. Psychiatry 33(1), 139\u2013149. https:\/\/doi.org\/10.1007\/s00787-023-02145-4 (2024).","journal-title":"Eur. Child. Adolesc. Psychiatry"},{"issue":"1","key":"10684_CR42","doi-asserted-by":"publisher","first-page":"18738","DOI":"10.1038\/s41598-023-45714-y","volume":"13","author":"M Cartabia","year":"2023","unstructured":"Cartabia, M., Finazzi, S. & Bonati, M. Differences between centers in functional outcome of patients with ADHD after 1 year from the time of diagnosis. Sci. Rep. 13(1), 18738. https:\/\/doi.org\/10.1038\/s41598-023-45714-y (2023).","journal-title":"Sci. Rep."},{"key":"10684_CR43","doi-asserted-by":"publisher","first-page":"f7474","DOI":"10.1136\/bmj.f7474","volume":"347","author":"M Bonati","year":"2013","unstructured":"Bonati, M. & Reale, L. Reducing overdiagnosis and disease mongering in ADHD in Lombardy. BMJ 347, f7474. https:\/\/doi.org\/10.1136\/bmj.f7474 (2013).","journal-title":"BMJ"},{"key":"10684_CR44","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1469-7610.2000.tb02345.x","volume":"41","author":"R Goodman","year":"2000","unstructured":"Goodman, R., Ford, T., Richards, H., Gatward, R. & Meltzer, H. The development and wellbeing assessment: Description and initial validation of an integrated assessment of child and adolescent psychopathology. J. Child Psychol. Psychiatry 41, 645\u2013655 (2000).","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10684_CR45","first-page":"197","volume":"13","author":"AIFA-Ministero della Salute","year":"2006","unstructured":"AIFA-Ministero della Salute. Disturbo da deficit di attenzione con iperattivit\u00e0 (ADHD): Le tappe per un uso razionale dei farmaci. Bollettino di Informazione sui Farmaci 13, 197\u2013203 (2006).","journal-title":"Bollettino di Informazione sui Farmaci"},{"key":"10684_CR46","unstructured":"Wechsler, D. Wechsler Intelligence Scale for Children\u2013III (WISC-III), 3th ed. (Organizzazioni Speciali, 2006)."},{"key":"10684_CR47","unstructured":"Wechsler, D. Wechsler Intelligence Scale for Children\u2013IV (WISC-IV), 4th ed. (Organizzazioni Speciali, 2012)."},{"key":"10684_CR48","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1023\/a:1022602400621","volume":"26","author":"CK Conners","year":"1998","unstructured":"Conners, C. K., Sitarenios, G., Parker, J. D. & Epstein, J. N. The revised Conners\u2019 parent rating scale (CPRS-R): Factor structure, reliability, and criterion validity. J. Abnorm Child. Psychol. 26, 257\u2013268. https:\/\/doi.org\/10.1023\/a:1022602400621 (1998).","journal-title":"J. Abnorm Child. Psychol."},{"key":"10684_CR49","unstructured":"Nobile, M., Alberti, B., Zuddas, A. CRS-R. Conners\u2019 Rating Scales. Revised. Manuale. (Giunti Editore, 2007)."},{"key":"10684_CR50","unstructured":"Hollingshead, A.B. Four Factor Index of Social Status. (Yale University, 1975)."},{"key":"10684_CR51","first-page":"28","volume":"4","author":"J Busner","year":"2007","unstructured":"Busner, J. & Targum, S. D. The clinical global impressions scale: Applying a research tool in clinical practice. Psychiatry 4, 28\u201337 (2007).","journal-title":"Psychiatry"},{"issue":"3","key":"10684_CR52","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1467-9280.2007.01882.x","volume":"18","author":"MS Fritz","year":"2007","unstructured":"Fritz, M. S. & Mackinnon, D. P. Required sample size to detect the mediated effect. Psychol Sci. 18(3), 233\u2013239. https:\/\/doi.org\/10.1111\/j.1467-9280.2007.01882.x (2007).","journal-title":"Psychol Sci."},{"key":"10684_CR53","unstructured":"Muth\u00e9n, B., & Muth\u00e9n, L. Mplus. In Handbook of Item Response Theory. 507\u2013518. (Chapman and Hall\/CRC, 2017)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10684-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10684-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10684-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T12:46:07Z","timestamp":1757249167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10684-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10684"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-10684-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"30 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25892"}}